Ornithine-δ-aminotransferase inhibits neurogenesis during Xenopus embryonic development

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 4, 2015, Pages 2486-2497

  Peng, Ying ^a   Cooper, Sandra K ^b   Li, Yi ^a   Mei, Jay M ^b   Qiu, Shuwei ^a   Borchert, Gregory L ^b   Donald, Steven P ^b   Kung, Hsiang Fu ^c   Phang, James M ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Development; Embryos; Neuralization; Ventralization; Xenopus

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ORNITHINE OXOACID AMINOTRANSFERASE; RNA; TRANSCRIPTION FACTOR OTX2;

ADULT; AMINO ACID SEQUENCE; ARTICLE; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; MALE; MUTATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; XENOPUS LAEVIS; ANIMAL; BIOSYNTHESIS; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS;

ANIMALS; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; NEUROGENESIS; ORNITHINE-OXO-ACID TRANSAMINASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; XENOPUS LAEVIS;

EID: 84939619040     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.15-16509     Document Type: Article

References (66)

1. Hagedorn CH, Phang JM. Catalytic transfer of hydride ions from NADPH to oxygen by the interconversions of proline and delta 1-pyrroline-5-carboxylate. Arch Biochem Biophys. 1986; 248:166-174.
2. Phang JM. The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr Top Cell Regul. 1985;25:91-132.
3. Fremeau RT Jr, Caron MG, Blakely RD. Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron. 1992;8: 915-926.
4. Renick SE, Kleven DT, Chan J, et al. The mammalian brain high-affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation of excitatory nerve terminals in rat forebrain. J Neurosci. 1999;19:21-33.
5. Gogos JA, Santha M, Takacs Z, et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet. 1999;21:434-439.
6. Liu H, Heath SC, Sobin C, et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA. 2002;99:3717-3722.
7. Bender HU, Almashanu S, Steel G, et al. Functional consequences of PRODH missense mutations. Am J Hum Genet. 2005;76:409-420.
8. Phang JM, Hu CA, Valle D. Disorders of proline and hydroxyproline metabolism. In: The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill; 2001:1821-1838.
9. Baumgartner MR, Hu CA, Almashanu S, et al. Hyperammone-mia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum Mol Genet. 2000;9:2853-2858.
10. Bicknell LS, Pitt J, Aftimos S, Ramadas R, Maw MA, Robertson SP. A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome. Eur J Hum Genet. 2008; 16:1176-1186.
11. Valle D, Simell O. The hyperornithinemias. In: The Metabolic and Molecular Bases of Inherited Disease. 8th ed. New York: McGraw-Hill Press; 2001:1857-1895.
12. Valle D, Simell O. The hyperornithinemias. In: The Metabolic and Molecular Bases ofInherited Disease. 7th ed. New York: McGraw-Hill Press; 1995:1147-1185.
13. Kaiser-Kupfer MI, Ludwig IH, de Monasterio FM, Valle D, Krieger I. Gyrate atrophy of the choroid and retina. Early findings. Ophthalmology. 1985;92:394-401.
14. Takki KK, Milton RC. The natural history of gyrate atrophy of the choroid and retina. Ophthalmology. 1981;88:292-301.
15. Simell O, Takki K. Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet. 1973;1:1031-1033.
16. Valle D, Kaiser-Kupfer MI, Del Valle LA. Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes. Proc Natl Acad Sci U S A. 1977;74: 5159-5161.
17. Brody LC, Mitchell GA, Obie C, et al. Ornithine delta-aminotransferase mutations in gyrate atrophy. Allelic heterogeneity and functional consequences. J Biol Chem. 1992;267: 3302-3307.
18. Inana G, Totsuka S, Redmond M, et al. Molecular cloning of human ornithine aminotransferase mRNA. Proc Natl Acad Sci USA. 1986;83:1203-1207.
19. Michaud J, Brody LC, Steel G, et al. Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotrans-ferase gene. Genomics. 1992;13:389-394.
20. Mitchell GA, Looney JE, Brody LC, et al. Human ornithine-delta-aminotransferase. cDNA cloning and analysis of the structural gene. J Biol Chem. 1988;263:14288-14295.
21. Ramesh V, Shaffer MM, Allaire JM, Shih VE, Gusella JF. Investigation of gyrate atrophy using a cDNA clone for human ornithine aminotransferase. DNA. 1986;5:493-501.
22. Wang T, Lawler AM, Steel G, Sipila I, Milam AH, Valle D. Mice lacking ornithine-delta-aminotransferase have paradoxical neonatal hypoornithinaemia and retinal degeneration. Nat Genet. 1995;11:185-190.
23. Bisaillon JJ, Radden LA II, Szabo, ET, et al. The retarded hair growth (rhg) mutation in mice is an allele of ornithine aminotransferase (OAT). Mol Genet Metab Rep. 2014;1:378-390.
24. Wang T, Steel G, Milam AH, Valle D. Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA. 2000;9:1224-1229.
25. Tseng HT, Shah R, Jamrich M. Function and regulation of FoxF1 during Xenopus gut development. Development. 2004; 131:3637-3647.
26. Nitta KR, Tanegashima K, Takahashi S, Asashima M. XSIP1 is essential for early neural gene expression and neural differentiation by suppression of BMP signaling. Dev Biol. 2004; 275:258-267.
27. Newport J, Kirschner M. A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription. Cell. 1982;30:687-696.
28. Sullivan SA, Akers L, Moody SA. FoxD5a, a Xenopus winged helix gene, maintains an immature neural ectoderm via transcriptional repression that is dependent on the C-terminal domain. Dev Biol. 2001;232:439-457.
29. Hong CS, Koo EH. Isolation and characterization of Drosoph-ila presenilin homolog. Neuroreport. 1997;8:665-668.
30. Jarriault S, Greenwald I. Suppressors of the egg-laying defective phenotype of sel-12 presenilin mutants implicate the CoREST corepressor complex in LIN-12/Notch signaling in C. elegans. Genes Dev. 2002;16:2713-2728.
31. Sive HL, Grainger RM, Harland RM. Early development of Xenopus laevis. In: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press; 2000:1-35.
32. De Jonge WJ, Dingemanse MA, de Boer PA, Lamers WH, Moorman AF. Arginine-metabolizing enzymes in the developing rat small intestine. Pediatr Res. 1998;43:442-451.
33. Heinanen K, Nanto-Salonen K, Leino L, et al. Gyrate atrophy of the choroid and retina: lymphocyte ornithine-delta-amino-transferase activity in different mutations and carriers. Pediatr Res. 1998;44:381-385.
34. Inana G, Chambers C, Hotta Y, et al. Point mutation affecting processing of the ornithine aminotransferase precursor protein in gyrate atrophy. J Biol Chem. 1989;264:17432-17436.
35. Mitchell GA, Brody LC, Sipila I, et al. At least two mutant alleles of ornithine delta-aminotransferase cause gyrate atrophy of the choroid and retina in Finns. Proc Natl Acad Sei U S A. 1989;86:197-201.
36. Peng Y, Xu RH, Mei JM, et al. Neural inhibition by c-Jun as a synergizing factor in bone morphogenetic protein 4 signaling. Neuroseienee. 2002;109:657-664.
37. Phang JM, Downing SJ, Valle DL, Kowaloff EM. A radioisotopic assay for proline oxidase activity. J Lab Clin Med. 1975;85: 312-317.
38. Fukui A, Nakamura T, Uchiyama H, Sugino K, Sugino H, Asashima M. Identification of activins A, AB, and B and follistatin proteins in Xenopus embryos. Dev Biol. 1994;163: 279-281.
39. Durston AJ, Timmermans JP, Hage WJ, et al. Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature. 1989;340:140-144.
40. Uochi T, Asashima M. XCIRP (Xenopus homolog of cold-inducible RNA-binding protein) is expressed transiently in developing pronephros and neural tissue. Gene. 1998;211: 245-250.
41. Cheung WK, Yang PH, Huang QH, et al. Identification of protein domains required for makorin-2-mediated neurogenesis inhibition in Xenopus embryos. Bioehem Biophys Res Commun. 2010;394:18-23.
42. Yang PH, Cheung WK, Peng Y, et al. Makorin-2 is a neurogenesis inhibitor downstream of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signal. J Biol Chem. 2008;283:8486-8495.
43. Kintner CR, Melton DA. Expression of Xenopus N-CAM RNA in ectoderm is an early response to neural induction. Development. 1987;99:311-325.
44. Blitz IL, Cho KW. Anterior neurectoderm is progressively induced during gastrulation: the role of the Xenopus homeobox gene orthodenticle. Development. 1995;121:993-1004.
45. Pannese M, Polo C, Andreazzoli M, et al. The Xenopus homologue of Otx2 is a maternal homeobox gene that demarcates and specifies anterior body regions. Development. 1995;121:707-720.
46. Wright CV, Morita EA, Wilkin DJ, De Robertis EM. The Xenopus XIHbox 6 homeo protein, a marker of posterior neural induction, is expressed in proliferating neurons. Development. 1990;109:225-234.
47. Kao KR, Elinson RP. The entire mesodermal mantle behaves as Spemann's organizer in dorsoanterior enhanced Xenopus laevis embryos. Dev Biol. 1988;127:64-77.
48. Peltola KE, Nanto-Salonen K, Heinonen OJ, et al. Ophthalmologic heterogeneity in subjects with gyrate atrophy of choroid and retina harboring the L402P mutation of ornithine aminotransferase. Ophthalmology. 2001;108:721-729.
49. Valtonen M, Nanto-Salonen K, Jaaskelainen S, et al. Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J Inherit Metab Dis. 1999;22:855-866.
50. Kesavan P, Wang L, Davis E, et al. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Bioehem J. 1997;322:57-63.
51. Kanno H, FujiiH,MiwaS.Expression and enzymatic characterization of human glucose phosphate isomerase (GPI) variants accounting for GPI deficiency. Blood Cells Mol Dis. 1998;24:54-61.
52. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300-305.
53. Pandhare J, Cooper SK, Phang JM. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-de pendent and -independent mechanisms. J Biol Chem. 2006; 281:2044-2052.
54. Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem. 2009;107:759-768.
55. Phang JM, Donald SP, Pandhare J, Liu Y. The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids. 2008;35:681-690.
56. Phang JM, Pandhare J, Zabirnyk O, Liu Y. PPARgamma and proline oxidase in cancer. PPAR Res. 2008;2008:542694.
57. Doimo M, Desbats MA, Baldoin MC, et al. Functional analysis of missense mutations of OAT, causing gyrate atrophy of choroid and retina. Hum Mutat. 2013;34:229-236.
58. Liu Y, Borchert GL, Surazynski A, Phang JM. Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene. 2008;27:6729-6737.
59. Willis A, Bender HU, Steel G, Valle D. PRODH variants and risk for schizophrenia. Amino Acids. 2008;35:673-679.
60. Reversade B, Escande-Beillard N, Dimopoulou A, et al. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet. 2009;41:1016-1021.
61. Hu CA, Lin WW, Obie C, Valle D. Molecular enzymology of mammalian Delta1-pyrroline-5-carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition. J Biol Chem. 1999;274: 6754-6762.
62. Wu G. Synthesis of citrulline and arginine from proline in enterocytes ofpostnatal pigs. Am JPhysiol. 1997;272:G1382-G1390.
63. Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond. Bioehem J. 1998;336:1-17.
64. Luk GD, Casero RA Jr. Polyamines in normal and cancer cells. Adv Enzyme Regul. 1987;26:91-105.
65. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Caneer Res. 1988;48:759-774.
66. Zheng L, Roeder RG, Luo Y. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell. 2003;114:255-266.